RhumbLine Advisers’s Verastem VSTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $320K | Buy |
83,678
+11,705
| +16% | +$56.6K | ﹤0.01% | 3036 |
|
|
2026
Q1 | $381K | Buy |
71,973
+11,469
| +19% | +$70.7K | ﹤0.01% | 2778 |
|
|
2025
Q4 | $467K | Buy |
60,504
+2,510
| +4% | +$22.4K | ﹤0.01% | 2701 |
|
|
2025
Q3 | $512K | Sell |
57,994
-1,559
| -3% | -$11.6K | ﹤0.01% | 2679 |
|
|
2025
Q2 | $247K | Buy |
59,553
+9,594
| +19% | +$60.1K | ﹤0.01% | 3111 |
|
|
2025
Q1 | $301K | Buy |
49,959
+12,330
| +33% | +$75.3K | ﹤0.01% | 2889 |
|
|
2024
Q4 | $195K | Buy |
37,629
+10,352
| +38% | +$40.8K | ﹤0.01% | 3211 |
|
|
2024
Q3 | $81.5K | Sell |
27,277
-1,516
| -5% | -$4.11K | ﹤0.01% | 3565 |
|
|
2024
Q2 | $85.8K | Buy |
28,793
+28,119
| +4,172% | +$232K | ﹤0.01% | 3554 |
|
|
2024
Q1 | $7.95K | Hold |
674
| – | – | ﹤0.01% | 3909 |
|
|
2023
Q4 | $5.49K | Hold |
674
| – | – | ﹤0.01% | 3965 |
|
|
2023
Q3 | $5.48K | Hold |
674
| – | – | ﹤0.01% | 3966 |
|
|
2023
Q2 | $5.01K | Buy |
+674
| New | +$4.68K | ﹤0.01% | 4088 |
|
|
2022
Q2 | – | Sell |
-13,953
| Closed | -$236K | – | 3249 |
|
|
2022
Q1 | $236K | Buy |
13,953
+39
| +0.3% | +$672 | ﹤0.01% | 2713 |
|
|
2021
Q4 | $342K | Sell |
13,914
-272
| -2% | -$8.58K | ﹤0.01% | 2666 |
|
|
2021
Q3 | $524K | Buy |
14,186
+564
| +4% | +$20.7K | ﹤0.01% | 2520 |
|
|
2021
Q2 | $665K | Sell |
13,622
-3,148
| -19% | -$131K | ﹤0.01% | 2429 |
|
|
2021
Q1 | $497K | Sell |
16,770
-781
| -4% | -$21.9K | ﹤0.01% | 2501 |
|
|
2020
Q4 | $449K | Buy |
17,551
+2,617
| +18% | +$52.6K | ﹤0.01% | 2484 |
|
|
2020
Q3 | $217K | Sell |
14,934
-2,511
| -14% | -$41.6K | ﹤0.01% | 2653 |
|
|
2020
Q2 | $360K | Buy |
+17,445
| New | +$462K | ﹤0.01% | 2484 |
|
|
2019
Q2 | – | Sell |
-9,234
| Closed | -$328K | – | 3007 |
|
|
2019
Q1 | $328K | Buy |
9,234
+1,916
| +26% | +$75.7K | ﹤0.01% | 2496 |
|
|
2018
Q4 | $295K | Buy |
7,318
+2,587
| +55% | +$158K | ﹤0.01% | 2552 |
|
|
2018
Q3 | $412K | Buy |
4,731
+564
| +14% | +$56.1K | ﹤0.01% | 2357 |
|
|
2018
Q2 | $344K | Buy |
+4,167
| New | +$255K | ﹤0.01% | 2464 |
|
|
2016
Q2 | – | Sell |
-3,769
| Closed | -$71K | – | 3026 |
|
|
2016
Q1 | $71K | Buy |
3,769
+338
| +10% | +$5.43K | ﹤0.01% | 2938 |
|
|
2015
Q4 | $77K | Buy |
3,431
+159
| +5% | +$3.77K | ﹤0.01% | 2982 |
|
|
2015
Q3 | $70K | Buy |
3,272
+183
| +6% | +$14.5K | ﹤0.01% | 2978 |
|
|
2015
Q2 | $280K | Buy |
3,089
+299
| +11% | +$31.6K | ﹤0.01% | 2697 |
|
|
2015
Q1 | $341K | Buy |
2,790
+606
| +28% | +$63.5K | ﹤0.01% | 2541 |
|
|
2014
Q4 | $240K | Buy |
2,184
+208
| +11% | +$22.5K | ﹤0.01% | 2698 |
|
|
2014
Q3 | $202K | Hold |
1,976
| – | – | ﹤0.01% | 2747 |
|
|
2014
Q2 | $215K | Buy |
1,976
+941
| +91% | +$102K | ﹤0.01% | 2792 |
|
|
2014
Q1 | $134K | Sell |
1,035
-58
| -5% | -$9.26K | ﹤0.01% | 2881 |
|
|
2013
Q4 | $150K | Hold |
1,093
| – | – | ﹤0.01% | 2899 |
|
|
2013
Q3 | $163K | Buy |
1,093
+8
| +0.7% | +$1.4K | ﹤0.01% | 2847 |
|
|
2013
Q2 | $181K | Buy |
+1,085
| New | +$131K | ﹤0.01% | 3033 |
|
Other funds holding VSTM
AC
RI
DTC
RA
NCM
SCM
RhumbLine Advisers's VSTM Position: Q2 2026 in Review
RhumbLine Advisers increased its Verastem (VSTM) stake by 16% in Q2 2026, buying an estimated $56.6K and bringing the position to 83,678 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #3036.
RhumbLine Advisers first reported a position in VSTM in Q2 2013 and has held it in 37 quarters since. The position peaked at $665K in Q2 2021. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.
- RhumbLine Advisers held 83,678 shares of Verastem worth $320K as of Q2 2026.
- RhumbLine Advisers bought 11,705 Verastem shares in Q2 2026, an estimated $56.6K.
- Verastem made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3036 holding.
- RhumbLine Advisers first reported a position in Verastem in Q2 2013 and has held it in 37 quarters since.
- RhumbLine Advisers's Verastem position peaked at $665K in Q2 2021.
- 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.